Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses

BACKGROUND: Phambili, the Merck (MRK)-Adenovirus Type 5 (Ad5) HIV-1 gag/pol/nef subtype B vaccine study, conducted in South Africa, suspended enrollment and vaccination when companion study, Step, was found non-efficacious. Although the vaccine did not prevent HIV-1 infection or lower viral-load set...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopkins, Kathryn L., Laher, Fatima, Otwombe, Kennedy, Churchyard, Gavin, Bekker, Linda-Gail, DeRosa, Stephen, Nchabeleng, Maphoshane, Mlisana, Koleka, Kublin, James, Gray, Glenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121165/
https://www.ncbi.nlm.nih.gov/pubmed/25090110
http://dx.doi.org/10.1371/journal.pone.0103446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121165/
https://www.ncbi.nlm.nih.gov/pubmed/25090110
http://dx.doi.org/10.1371/journal.pone.0103446

Ejemplares similares